Alembic Ltd Stock Price Today (NSE: ALEMBICLTD)
Fundamental Score
Alembic Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Alembic Ltd share price today is ₹90.79, up +1.73% on NSE/BSE as of 17 June 2026. Alembic Ltd (ALEMBICLTD) is a Small-cap company in the Residential, Commercial Projects sector with a market capitalisation of ₹2.57K (Cr). The 52-week high for ALEMBICLTD share price is ₹125.54 and the 52-week low is ₹70.46. At a P/E ratio of 7.95x, ALEMBICLTD is currently trading below its industry average P/E of 35.86x. The company has a Return on Equity (ROE) of 13.69% and a debt-to-equity ratio of 0.00.
Alembic Ltd Share Price Chart — NSE/BSE Historical Performance
Alembic Ltd share price chart: -5.82% return over the past month. 52-week high ₹125.54, 52-week low ₹70.46.
Alembic Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹86.41 | ₹88.28 | ₹85.86 | ₹87.35 | 1.82L (Cr) | |
| ₹88.95 | ₹88.95 | ₹85.76 | ₹86.65 | 1.89L (Cr) | |
| ₹87.40 | ₹88.90 | ₹87.26 | ₹87.64 | 2.77L (Cr) | |
| ₹88.12 | ₹88.12 | ₹86.97 | ₹87.13 | 2.56L (Cr) | |
| ₹87.62 | ₹88.89 | ₹87.51 | ₹87.91 | 1.71L (Cr) | |
| ₹88.19 | ₹89.50 | ₹86.50 | ₹87.62 | 3.13L (Cr) | |
| ₹87.03 | ₹88.10 | ₹87.03 | ₹87.34 | 1.37L (Cr) | |
| ₹88.75 | ₹89.76 | ₹87.06 | ₹87.41 | 1.72L (Cr) | |
| ₹87.00 | ₹88.57 | ₹86.02 | ₹87.27 | 3.71L (Cr) | |
| ₹88.55 | ₹91.26 | ₹88.55 | ₹89.84 | 1.79L (Cr) |
Alembic Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹88.95 | ₹88.95 | ₹85.76 | ₹87.35 | -1.80% | |
| ₹91.20 | ₹96.37 | ₹86.02 | ₹87.64 | -3.90% | |
| ₹72.09 | ₹95.00 | ₹72.09 | ₹91.20 | +26.51% | |
| ₹86.80 | ₹91.00 | ₹70.46 | ₹70.90 | -18.32% | |
| ₹92.20 | ₹100.87 | ₹89.90 | ₹91.72 | -0.52% | |
| ₹101.19 | ₹105.00 | ₹89.80 | ₹92.93 | -8.16% | |
| ₹100.00 | ₹106.39 | ₹94.83 | ₹101.19 | +1.19% | |
| ₹99.50 | ₹103.40 | ₹97.38 | ₹100.04 | +0.54% | |
| ₹99.78 | ₹104.28 | ₹96.31 | ₹99.40 | -0.38% | |
| ₹101.53 | ₹108.50 | ₹99.40 | ₹99.78 | -1.72% | |
| ₹112.00 | ₹114.80 | ₹100.50 | ₹101.53 | -9.35% | |
| ₹124.70 | ₹124.70 | ₹110.56 | ₹112.12 | -10.09% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Alembic is a generics grinder; steady execution, not explosive growth, is the name of the game.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Alembic Pharma received USFDA final approval for Methotrexate Injection. The approval covers both multi-dose (50 mg/2 mL) and single-dose (1 g/40 mL) formats. Alembic Pharma also launched its second 100-day 'Saksham Niveshak' campaign to facilitate dividend claims and KYC updates for shareholders.
CORE STORY (THE REAL GAME)
Alembic is a play on steady, if unspectacular, US generics approvals. They're building a diversified portfolio to de-risk reliance on any single blockbuster drug. Not a high-growth story, but a grind-it-out generics business.
- USFDA approval for Methotrexate Injection
- Focus on regulated markets and injectables
- Saksham Niveshak campaign to facilitate dividend claims
- Faster than expected USFDA approvals
- Successful penetration of the injectables market
- Acquisition of a strategic asset
- Negative free cash flow
- Intense pricing pressure in US generics market
- Compliance risk in regulated markets
FII decreased holdings by 0.12%.
Real estate market is seeing record-breaking deals and soaring demand for luxury homes.
No. Free Cash Flow 5Y: ₹-84.37 Cr
Expect steady, incremental growth driven by USFDA approvals and focus on injectables. Key risk is pricing pressure and compliance in the US generics market.
Primary Thesis Risk
US generics pricing pressure and compliance risks can derail the entire thesis.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Alembic Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Alembic Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ALEMBICLTD across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Operating Margins (32.80%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 7.95 vs Industry: 35.86)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (24.58% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (65.59x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (70.88%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Suboptimal ROCE (6.90%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Weak Earnings Growth (-1.12% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-1.12% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-84.37 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.43%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Alembic Ltd vs Residential, Commercial Projects Peers
Peer Comparison - Residential, Commercial Projects
Compare Alembic Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Alembic LtdAlembic Ltd...Selected✓ ALEMBICLTD • 506235 | 49/100 | ₹90.79₹91 | ₹2574.50₹2574.50 | 7.95Average 8.0 Average | 13.69%Average 13.69% Average | 6.90%Poor 6.90% Poor | 0.00Excellent 0.0 Excellent | -1.12%Poor -1.12% Poor | 24.58%Excellent 24.58% Excellent | 2.39% |
DLF LtdDLF Ltd... DLF • 532868 | 49.2/100 | ₹593.90₹594 | ₹176317.23₹176317.23 | 45.68Average 45.7 Average | 11.36%Average 11.36% Average | 6.51%Poor 6.51% Poor | 0.04Excellent 0.0 Excellent | 90.95%Excellent 90.95% Excellent | 5.62%Good 5.62% Good | 0.84% |
Prestige Estates Projects LtdPrestige Estate... PRESTIGE • 533274 | 31.7/100 | ₹1399.80₹1400 | ₹71505.13₹71505.13 | 93.41Average 93.4 Average | 3.48%Poor 3.48% Poor | 7.66%Poor 7.66% Poor | 0.92Good 0.9 Good | 4.12%Average 4.12% Average | -1.99%Poor -1.99% Poor | 0.11% |
Godrej Properties LtdGodrej Properti... GODREJPROP • 533150 | 45.5/100 | ₹1788.60₹1789 | ₹63179.28₹63179.28 | 40.77Average 40.8 Average | 8.98%Poor 8.98% Poor | 6.57%Poor 6.57% Poor | 0.89Good 0.9 Good | 40.91%Excellent 40.91% Excellent | 15.06%Excellent 15.06% Excellent | 0.00% |
Phoenix Mills LtdPhoenix Mills L... PHOENIXLTD • 503100 | 62/100 | ₹1771.80₹1772 | ₹61866.27₹61866.27 | 57.83Average 57.8 Average | 9.36%Poor 9.36% Poor | 10.75%Average 10.75% Average | 0.46Excellent 0.5 Excellent | 23.32%Excellent 23.32% Excellent | 14.48%Good 14.48% Good | 0.14% |
Oberoi Realty LtdOberoi Realty L... OBEROIRLTY • 533273 | 54.3/100 | ₹1692.60₹1693 | ₹58897.53₹58897.53 | 26.38Average 26.4 Average | 14.67%Average 14.67% Average | 17.73%Good 17.73% Good | 0.18Excellent 0.2 Excellent | 25.94%Excellent 25.94% Excellent | 18.76%Excellent 18.76% Excellent | 0.49% |
Brigade Enterprises LtdBrigade Enterpr... BRIGADE • 532929 | 62.5/100 | ₹659.75₹660 | ₹21966.91₹21966.91 | 27.62Average 27.6 Average | 14.92%Average 14.92% Average | 13.34%Average 13.34% Average | 0.83Good 0.8 Good | 36.56%Excellent 36.56% Excellent | 14.03%Good 14.03% Good | 0.28% |
Anant Raj LtdAnant Raj Ltd... ANANTRAJ • 515055 | 68.1/100 | ₹508.30₹508 | ₹20611.94₹20611.94 | 41.81Average 41.8 Average | 10.89%Average 10.89% Average | 11.17%Average 11.17% Average | 0.13Excellent 0.1 Excellent | 73.92%Excellent 73.92% Excellent | 49.46%Excellent 49.46% Excellent | 0.13% |
Sobha LtdSobha Ltd... SOBHA • 532784 | 42.9/100 | ₹1395.00₹1395 | ₹16352.79₹16352.79 | 109.97Average 110.0 Average | 2.68%Poor 2.68% Poor | 6.44%Poor 6.44% Poor | 0.23Excellent 0.2 Excellent | -19.57%Poor -19.57% Poor | 1.47%Average 1.47% Average | 0.20% |
Signatureglobal India LtdSignatureglobal... SIGNATURE • 543990 | 39/100 | ₹801.40₹801 | ₹15880.75₹15880.75 | 204.18Average 204.2 Average | 14.72%Average 14.72% Average | 5.42%Poor 5.42% Poor | 3.56Poor 3.6 Poor | 30.05%Excellent 30.05% Excellent | 59.56%Excellent 59.56% Excellent | 0.00% |
Equinox India Developments LPEquinox India D... EMBDL • 532832 | 0/100 | ₹59.79₹60 | ₹10648.01₹10648.01 | — — | 2.53%Poor 2.53% Poor | 3.19%Poor 3.19% Poor | 0.46Excellent 0.5 Excellent | -7.08%Poor -7.08% Poor | -7.79%Poor -7.79% Poor | 0.00% |
Top Residential, Commercial Projects Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- DLF Ltd share price176317.23 Cr
- Prestige Estates Projects Ltd share price71505.13 Cr
- Godrej Properties Ltd share price63179.28 Cr
- Phoenix Mills Ltd share price61866.27 Cr
- Oberoi Realty Ltd share price58897.53 Cr
Alembic Ltd PE Ratio History
Historical price-to-earnings ratio for ALEMBICLTD — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹12.10 | ₹101.19 | 8.4x |
| FY 2024 | ₹10.46 | ₹131.66 | 12.6x |
| FY 2023 | ₹7.42 | ₹90.50 | 12.2x |
| FY 2022 | ₹8.65 | ₹71.20 | 8.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Alembic Ltd Dividend History
Annual cash dividends paid by ALEMBICLTD — dividend yield 2.39%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹61.17 Cr |
| FY 2024 | ₹56.23 Cr |
| FY 2023 | ₹45.92 Cr |
| FY 2022 | ₹5.15 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Alembic Ltd Quarterly Performance
Latest quarterly metrics for ALEMBICLTD — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
5.58%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
6.17%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
24.58%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-1.12%
Compounded annual net profit growth over 5 years
Alembic Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ALEMBICLTD — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Alembic Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Alembic Ltd (ALEMBICLTD) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Alembic Ltd
About ALEMBICLTD (Alembic Ltd)
Alembic Ltd is a dynamic force reshaping the landscape of Indian real estate, crafting vibrant residential communities and strategically designed commercial spaces. The company's r...esidential portfolio is distinguished by its commitment to creating homes that resonate with modern lifestyles, blending aesthetic appeal with functional design. From spacious apartments bathed in natural light to meticulously planned villas offering privacy and tranquility, Alembic Ltd focuses on fostering a sense of community and well-being for its residents. Attention to detail is paramount, with high-quality materials, lush landscaping, and thoughtful amenities integrated seamlessly into each project. The aim is not just to build houses, but to cultivate havens where families can thrive and create lasting memories. On the commercial front, Alembic Ltd develops innovative and adaptable workspaces that cater to the evolving needs of businesses. These projects are more than just buildings; they are catalysts for collaboration, productivity, and growth. Prioritizing strategic locations and intelligent infrastructure, Alembic's commercial properties offer a competitive edge to tenants. State-of-the-art facilities, flexible floor plans, and sustainable design principles are hallmarks of their approach. Understanding the importance of image, Alembic Ltd creates prestigious business addresses that project professionalism and inspire confidence. Whether it's a cutting-edge office complex or a retail hub designed to attract customers, their projects are tailored to maximize value for businesses and investors alike. Beyond construction, Alembic Ltd offers comprehensive real estate solutions, providing project management and marketing consultancy services to ensure successful project outcomes. This end-to-end approach, coupled with a commitment to transparency and integrity, has earned them a reputation as a trusted partner in the industry. Furthermore, Alembic Ltd strategically leases commercial properties, providing a stable income stream and further solidifying their position in the real estate market. The company also continues to engage in research and development, not only within their pharmaceutical division but also exploring innovative construction techniques and sustainable building materials that will shape the future of their real estate endeavors.
Company Details
Key Leadership
Corporate Events
ALEMBICLTD Share Price: Frequently Asked Questions
What is the current share price of Alembic Ltd?
Alembic Ltd (ALEMBICLTD) trades at ₹90.79 on NSE and BSE. Market cap ₹2.57K (Cr). Educational data only.
What is the P/E ratio of Alembic Ltd?
Alembic Ltd has a P/E of 7.95x vs industry average 35.86x.
What is the Bull Run score for Alembic Ltd?
Alembic Ltd has a Bull Run score of 49/100 based on 25+ financial parameters.
Does Alembic Ltd pay dividends?
Alembic Ltd has a dividend yield of 2.39%. Past dividends don't guarantee future payments.
What is the ROE of Alembic Ltd?
Alembic Ltd has ROE of 13.69%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Alembic Ltd?
Alembic Ltd has debt-to-equity of 0.00.
Is Alembic Ltd a good investment?
Bull Run gives Alembic Ltd a score of 49/100. This is not investment advice — consult a SEBI-registered advisor.